|
| Status |
Public on May 14, 2022 |
| Title |
LOUCY cell line with MEF2C construct, no overexpression. Replicate 2 [M-2] |
| Sample type |
RNA |
| |
|
| Source name |
LOUCY cell line with MEF2C construct, no overexpression
|
| Organism |
Homo sapiens |
| Characteristics |
cell line: LOUCY
genotype/variation: MEF2C construct, no overexpression
treatment: without doxycyline
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Trizol extraction of total RNA was performed according to manufacturer's instructions
|
| Label |
biotin
|
| Label protocol |
standard Affymetrix protocol
|
| |
|
| Hybridization protocol |
standard Affymetrix protocol
|
| Scan protocol |
standard Affymetrix protocol
|
| Data processing |
Data analysis was performed in R version 3.6.3. The Affy package, version 1.64.0, was used for Robust Multichip Average (RMA) normalization.
|
| |
|
| Submission date |
Oct 18, 2020 |
| Last update date |
May 14, 2022 |
| Contact name |
Rico Hagelaar |
| E-mail(s) |
R.Hagelaar@prinsesmaximacentrum.nl
|
| Organization name |
Princess Maxima Center
|
| Street address |
Heidelberglaan 25
|
| City |
Utrecht |
| ZIP/Postal code |
3584CS |
| Country |
Netherlands |
| |
|
| Platform ID |
GPL570 |
| Series (2) |
| GSE159506 |
The MEF2C oncogene opposes Notch signalling in T versus B lineage decision and drives leukemia in the thymus context [array] |
| GSE160409 |
The MEF2C oncogene opposes Notch signalling in T versus B lineage decision and drives leukemia in the thymus context |
|
